OncoAlert
@OncoAlert
Followers
39K
Following
119K
Media
4K
Statuses
107K
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
Worldwide
Joined March 2019
The OncoAlert🚨Weekly Round Up .Covering the TOP of the week July 4-10, 2025 . REGISTER at OR . Discussing:.✅News From Industry: durvalumab in #BladderCancer.✅PRIM-B in metastatic #BreastCancer .✅Breastfeeding after breast
0
17
42
RT @JGeriOnc: Oncologist perspectives on the acceptability, appropriateness, and feasibility of the Cancer and Aging Research Group (CARG)….
0
4
0
RT @DrYukselUrun: Ultra-processed foods are everywhere; cheap, easy, addictive. But they quietly fuel the obesity crisis. #obesity @Onco….
0
5
0
RT @JournalCancer: New review | The role of body composition in the development of diabetes mellitus among childhood cancer survivors, and….
0
3
0
RT @JournalCancer: .@cityofhope researcher Pamela S. Becker MD, PhD comments on the recent retrospective study by @DrHKantarjian et al eval….
0
5
0
RT @Erman_Akkus: 📗Early-onset gastrointestinal cancers.@BJSurgery . ✅A comprehensive review. 👉 #cancer #oncology #M….
0
12
0
RT @AlexisLevee: Excited to share our review of side effects of novel and emerging #breastcancer therapies in the @ASCO Educational Book. V….
0
3
0
RT @ElisaAgostinett: The last @OncoAlert newsletter is out📩 today featuring the BRCA BCY paper on breastfeeding in BRCA-mut #breastcancer!….
0
5
0
RT @GillSharlene: 📛bolus!.👇another reminder that omitting the 5FU bolus in 5FU-based metastatic #GIcancer protocols is the right thing to d….
0
7
0
RT @ABCGlobalAll: Advancements in medical treatment for #breastcancer over the past century have been enormous, however, the history of #Ad….
0
2
0
RT @MarioBalsaMD: 🚨ACCORD trial (@JAMAOnc): adj. therapy in resected extrahepatic CCA & gallbladder cancer (93 pts | 3 Chinese centers): ht….
0
15
0
RT @TresUramigas: 🏃El ejercicio estructurado postQT en ca colon estadio II/III demuestra beneficio en SLE (HR 0.72):.📌SLE 5 años: 74% vs 80….
0
6
0
RT @to_be_elizabeth: 📌 Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma 🧠. 🔗 .
0
2
0
RT @JAMAOnc: The management of brain metastases in EGFR-variant and ALK-positive NSCLC patients remains uncertain, with evidence suggesting….
0
24
0
RT @to_be_elizabeth: 📌 Genomic landscape of hormone therapy‑resistant HR‑positive,.HER2‑negative breast cancer. 🧬 What drives hormone thera….
0
15
0
RT @Erman_Akkus: 💉BL-B01D1 for metastatic esophageal SCC.@NatureMedicine . ➡️Bispecific antibody–drug conjugate targeting EGFR and HER3.➡️P….
0
10
0
RT @nataliagandur: 🌟Therapeutic Targeting of MMR-Deficient Cancers🌟.🖋️ Paul Johannet, Benoit Rousseau, Carol Aghajanian,.@MikeFooteMD @MSKC….
0
15
0
RT @PGrivasMDPhD: Thanks @VivekSubbiah for your exceptional work in drug development & commitment to equitable access to therapies! I recal….
0
8
0
RT @OscarTahuahua: Post-hoc Ph3 trial.Pretreatment Emotional Distress in adv. Melanoma was linked to lower ORR with TIL Tx (37% vs 69%) & 2….
0
5
0
RT @Abdallah81MD: 🧵7/🧠 Takeaways:.🔹 Nanobody CAR-T is a promising new frontier.🔹 Strong activity in tough-to-treat subtypes.🔹 Infection ris….
0
5
0
RT @Erman_Akkus: 📋Environmental Risk Factors for Liver Cancer.@HEP_Journal . 👉 #cancer #oncology #liver #MedX @Onco….
0
10
0